News

May 12, 2021

Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis

Vancouver, British Columbia – May 12, 2021 – Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific […]
Read More >